ArticlePDF Available

Hybrid Upconversion Nanomaterials for Optogenetic Neuronal Control

Authors:
  • Nokia Bell Labs, Murray Hill, NJ

Abstract and Figures

Nanotechnology-based approaches offer the chemical control required to develop precision tools suitable for applications in neuroscience. We report a novel approach employing hybrid upconversion nanomaterials, combined with the photoresponsive ion channel channelrhodopsin-2 (ChR2), to achieve near-infrared light (NIR)-mediated optogenetic control of neuronal activity. Current optogenetic methodologies rely on using visible light (e.g. 470 nm blue light), which tends to exhibit high scattering and low tissue penetration, to activate ChR2. In contrast, our approach enables the use of 980 nm NIR light, which addresses the short-comings of visible light as an excitation source. This was facilitated by embedding upconversion nanomaterials, which can convert NIR light to blue luminescence, into polymeric scaffolds. These hybrid nanomaterial scaffolds allowed for NIR-mediated neuronal stimulation, with comparable efficiency as that of 470 nm blue light. Our platform was optimized for NIR-mediated optogenetic control by balancing multiple physicochemical properties of the nanomaterial (e.g. size, morphology, structure, emission spectra, concentration), thus providing an early demonstration of rationally-designing nanomaterial-based strategies for advanced neural applications.
Content may be subject to copyright.
Nanoscale
COMMUNICATION
Cite this: DOI: 10.1039/c5nr03411f
Received 24th May 2015,
Accepted 12th September 2015
DOI: 10.1039/c5nr03411f
www.rsc.org/nanoscale
Hybrid upconversion nanomaterials for
optogenetic neuronal control
Shreyas Shah,
a
Jing-Jing Liu,
b
Nicholas Pasquale,
a
Jinping Lai,
a
Heather McGowan,
b
Zhiping P. Pang*
b
and Ki-Bum Lee*
a
Nanotechnology-based approaches oer the chemical control
required to develop precision tools suitable for applications in
neuroscience. We report a novel approach employing hybrid
upconversion nanomaterials, combined with the photoresponsive
ion channel channelrhodopsin-2 (ChR2), to achieve near-infrared
light (NIR)-mediated optogenetic control of neuronal activity.
Current optogenetic methodologies rely on using visible light
(e.g. 470 nm blue light), which tends to exhibit high scattering and
low tissue penetration, to activate ChR2. In contrast, our approach
enables the use of 980 nm NIR light, which addresses the short-
comings of visible light as an excitation source. This was facilitated
by embedding upconversion nanomaterials, which can convert
NIR light to blue luminescence, into polymeric scaolds. These
hybrid nanomaterial scaolds allowed for NIR-mediated neuronal
stimulation, with comparable eciency as that of 470 nm blue
light. Our platform was optimized for NIR-mediated optogenetic
control by balancing multiple physicochemical properties of the
nanomaterial (e.g. size, morphology, structure, emission spectra,
concentration), thus providing an early demonstration of ration-
ally-designing nanomaterial-based strategies for advanced neural
applications.
The mammalian brain is a phenomenal piece of organic
machinery, consisting of an intricate network of neurons dis-
persed in a mixture of chemical and biochemical constituents.
While remarkable advances have been made to better under-
stand the brain, the intrinsic complexity of the brain makes it
dicult to probe the innate neuronal connectivity and to
further modulate this activity. This is partly due to challenges
in developing tools to eectively interact with the type of
neurocircuitry found in the brain. Yet, given that the biomole-
cular interactions and chemical communication in the brain
occur at the nanoscale, there is great interest in leveraging
advances in nanotechnology for neuroscience research.
1
The
reproducible control of chemical reactions and advanced
nanoscience have enabled the generation of numerous types of
nanomaterials and nanostructures with well-defined compo-
sitions, shapes and properties. This oers tremendous
promise for creating a seamless integration of neural cells with
synthetic materials, which can be further exploited to achieve
improved control of neuronal activity and function. In this
way, nanotechnology-based methods can be rationally-
designed to interface with neural systems and to address
prevalent challenges in neuroscience.
Herein, we demonstrate a unique application of inorganic
organic hybrid nanomaterials to the field of optogenetics.
Optogenetics is a revolutionary technology that has trans-
formed the field of neuroscience, allowing for the optical
control of neuronal activity by using light (opto) and gene-
tically-encoded photosensitive proteins (genetics).
2,3
In the
last decade, optogenetic approaches have been successfully uti-
lized to explore numerous neural states and disorders includ-
ing fear, anxiety, addiction, reward-seeking behavior, autism
and Parkinsons disease.
4
While it has facilitated novel investi-
gations that were previously infeasible, the ecient opto-
genetic manipulation of neural activity is contingent on
delivering a sucient dose of light to the target neuronal
cells.
5
Visible light (400600 nm) has been primarily used in
this regard to stimulate the photoresponsive opsin proteins
(e.g. channelrhodopsins, ChR, that are activated by 470 nm
blue light). A number of groups have also attempted to achieve
optogenetic control using other wavelengths of illumination
such as red-shifted light sources (>600 nm),
6,7
which can oer
opportunities for multiplexed stimulation. The most common
approach to implement this strategy has involved the combi-
nation of genome-wide screening and complex molecular
engineering to generate new variants of microbial opsin that
are sensitive to red light.
8
However, such a strategy tends to
require balancing numerous opsin-dependent design consider-
ations including spectral specificity, optimal expression in
Electronic supplementary information (ESI) available. See DOI: 10.1039/
c5nr03411f
a
Department of Chemistry & Chemical Biology, Rutgers, The State University of New
Jersey, Piscataway, NJ, USA. E-mail: kblee@rutgers.edu; http://kblee.rutgers.edu/;
Fax: +1 732-445-5312; Tel: +1 848-445-2081
b
Child Health Institute of New Jersey and Department of Neuroscience and Cell
Biology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
E-mail: pangzh@rwjms.rutgers.edu; Fax: +1 732-235-8612; Tel: +1 732-235-8074
This journal is © The Royal Society of Chemistry 2015 Nanoscale
Published on 23 September 2015. Downloaded by RUTGERS STATE UNIVERSITY on 29/09/2015 15:59:38.
View Article Online
View Journal
target cells, ecient cellular tracking to the plasma mem-
brane and optimal kinetics/ion specificity.
9
While valuable,
developing optogenetic approaches employing highly red-
shifted light has proven to be technically challenging.
In this work, we have developed an upconversion nano-
material-based system to act as a mediator for facilitating opto-
genetic control using near-infrared (NIR) light (980 nm).
Upconversion nanoparticles (UCNPs) have attracted significant
biomedical interest due to their inherent ability to emit high-
energy visible light upon excitation with low-energy NIR
light.
10
UCNPs possess a number of favorable characteristics
compared to conventional fluorescent materials including
high resistance to photoblinking and photobleaching, long
luminescence lifetimes and high signal-to-noise ratio due to
weak background autofluorescence.
11
Moreover, by carefully
controlling the experimental conditions during the synthesis
process, the physicochemical properties of UCNPs (e.g. size,
emission spectra, surface chemistry) can be finely-tuned based
on the application of interest.
12
So far, these features have
made UCNPs particularly ideal for numerous bio-applications
including cellular labeling, imaging and drug delivery.
1315
By
generating a neuralmaterial interface using UCNP-embedded
polymer hybrid scaolds, we provide one of the first demon-
strations of upconversion nanomaterials as NIR-excitable
internal light sources to achieve optogenetic control of
mammalian neuronal activity (Fig. 1).
Acquiring optogenetic control of neurons relies on the
exogenous expression of light-sensitive ion channels within
the neuronal plasma membrane.
16
Channelrhodopsin-2
(ChR2) is one example of a microbial ion channel that con-
ducts cation influx upon blue light illumination
(470475 nm).
17
The stable expression of ChR2 in mamma-
lian neurons can thus render the neurons sensitive to acti-
vation with blue light.
2
Given that the blue light-responsive
ChR2 is well-established and widely-used in optogenetics, we
sought to design UCNPs that can activate ChR2 upon NIR illu-
mination. The upconversion process (from NIR light to visible
light) in UCNPs is permitted by the doping of trivalent lantha-
nide ions within a host matrix.
10
Among other synthetic vari-
ables, selecting the proper lanthanide dopants is a critical
factor that determines the wavelength-specific luminescence
spectrum of the UCNP.
18
To this end, a combination of the
lanthanide ions Yb
3+
(a sensitizer, which has an absorption
cross-section in the NIR spectral region) and Tm
3+
(an activa-
tor, which has optical emission in the blue spectral region) is
reported to be a suitable pair to achieve blue emission
(475 nm).
19,20
We selected to employ Yb
3+
/Tm
3+
-doping for
our study, since the resulting upconverted blue emission over-
laps with the excitation spectra of ChR2,
21
thus suggesting the
possibility for UCNP-mediated optogenetic activation.
We sought to synthesize monodispersed UCNPs that exhibit
strong upconversion luminescence under NIR illumination. To
this end, we synthesized β-hexagonal-phase UCNPs consisting
of a sodium yttrium fluoride (NaYF
4
) host matrix co-doped
with Yb
3+
/Tm
3+
using a co-precipitation method from a pre-
vious report.
22
With modifications to the experimental con-
ditions and further optimization, we synthesized NaYF
4
:Yb
3+
/
Tm
3+
UCNPs with 30 mol% Yb
3+
and 0.2 mol% Tm
3+
. Trans-
mission electron microscopy (TEM) shows a spherical mor-
phology of the particles, with an average diameter of 36.2 ±
1.5 nm (Fig. 2a). In order to preserve the optical integrity of
the nanoparticles, we further coated the nanoparticles with an
Fig. 1 Schematic diagram depicting the generation and application of polymerUCNP hybrid scaolds for optogenetic neuronal activation. Up-
conversion nanoparticles (UCNPs) were embedded within polymeric lms to form biocompatible hybrid scaolds for neuronal culture. The UCNPs
served as internally excitable light sources that convert NIR light into blue light, thus facilitating optogenetic activation of channelrhodopsin (ChR)-
expressing neurons.
Communication Nanoscale
Nanoscale This journal is © The Royal Society of Chemistry 2015
Published on 23 September 2015. Downloaded by RUTGERS STATE UNIVERSITY on 29/09/2015 15:59:38.
View Article Online
inert thin-shell of NaYF
4
. This is reported to be an important
step because lanthanide dopants exposed on the nanoparticle
surface can undergo deactivation due to surface defects, lattice
strains and interactions with the surrounding solvents.
23,24
An
inert shell can thus minimize surface quenching-induced
emission loss and preserve high UCNP luminescence.
25
The
epitaxial growth of a NaYF
4
shell was carried out on the UCNP
cores as reported previously.
24
TEM confirmed the shell for-
mation and the monodisperity of the resulting coreshell
UCNPs, which displayed an average diameter of 46.7 ± 2.4 nm
(Fig. 2a). The coreshell UCNPs exhibited an absorption peak
at 980 nm (Fig. S1 in ESI) and peak emission in the blue spec-
tral region at 475 nm upon excitation with 980 nm NIR light
(Fig. 2b and c). Powder X-ray diraction (PXRD) patterns
exhibit peak positions and intensities that can be indexed with
the β-hexagonal phase NaYF
4
crystal structure,
26
further con-
firming the high crystallinity of the UCNPs (Fig. 2d). The
quantum yield of our coreshell UCNPs is expected to be
13%, based on previous reports.
27,28
With the as-synthesized coreshell UCNPs exhibiting favor-
able spectral properties for ChR2 activation, we next encapsu-
lated the particles within a biomaterial scaold. Biomaterials
are becoming increasingly useful for neural engineering since
they can be tailored to interact with nervous tissue on a mole-
cular, cellular and tissue level.
29
At the same time, biomater-
ials can serve as reliable scaolds to load and immobilize
cells, biomolecules and other materials over long periods of
time. To this end, compared to a solution-based delivery of
UCNPs that can suer from diusion of particles over time
and high variability in particle distribution, we elected to
embed the UCNPs within a biomaterial scaold for our
studies. We used poly(lactic-co-glycolic acid) (PLGA) as the
underlying biomaterial scaold, since it is biocompatible, bio-
degradable, FDA-approved and widely-used for in vivo trans-
plantation in the nervous system.
30,31
In order to acquire a
uniform nanoparticle distribution within the polymer matrix,
UCNPs from a stock solution were first mixed with the PLGA
solution. After thorough mixing to disperse the UCNPs, the
Fig. 2 Monodisperse coreshell UCNPs with blue emission upon near-infrared excitation were synthesized. (a) Transmission electron microscopy
(TEM) image of core NaYF
4
:Yb
3+
/Tm
3+
(30/0.2 mol%) nanoparticles (left, scale bar: 100 nm) and core@shell NaYF
4
:Yb
3+
/Tm
3+
(30/0.2 mol%)@NaYF
4
UCNPs (right, scale bar: 50 nm). (b) Photographic image of a cuvette with a suspension of UCNPs under laser excitation at 980 nm. (c) Upconversion
emission spectrum of coreshell UCNPs in hexane solution (1 mg mL
1
) under near-infrared light excitation at 980 nm. (d) Powder X-ray diraction
(PXRD) patterns of the coreshell UCNPs, showing all peaks to be well-indexed in accordance with the β-hexagonal-phase NaYF
4
crystal structure
(Joint Committee on Powder Diraction Standards le no. 16-0334).
Nanoscale Communication
This journal is © The Royal Society of Chemistry 2015 Nanoscale
Published on 23 September 2015. Downloaded by RUTGERS STATE UNIVERSITY on 29/09/2015 15:59:38.
View Article Online
PLGAUCNP solution was spin-coated to form thin films on
circular glass coverslips (Fig. 3a). A number of parameters were
optimized including the amount of UCNP loading, percentage
of PLGA and speed of spin-coating (see ESIfor details). Flex-
ible thin films (0.5 µm thickness) of PLGAUCNP were gene-
rated that could be peeled from the glass coverslip (Fig. 3b).
Moreover, the hybrid scaolds showed blue luminescence
under NIR irradiation, owing to the distribution of UCNPs
throughout the polymer film (Fig. 3b). This luminescence
spectra of the hybrid scaold was evaluated using fluorescence
emission spectroscopy (Fig. S2 in ESI), which confirmed the
optical integrity and presence of UCNPs within the polymer
films. Increasing the power of NIR illumination was further
observed to exponentially increase blue light emission from
the scaolds, exhibiting a linear relationship on a double log-
arithmic scale (Fig. S3 in ESI). Further varying the initial
amount of UCNPs mixed with the PLGA solution (prior to
spin-coating) enabled the generation of films with varying con-
centrations of embedded UCNPs (quantification shown in
Table S1), which were characterized using scanning electron
microscopy (SEM) (Fig. S4 in ESI) and atomic force
microscopy (AFM) (Fig. S5 in ESI). By tuning both the concen-
tration of UCNPs embedded within the film and the power of
NIR illumination, a range of blue emission output can be
achieved (Fig. S6 in ESI).
The polymerUCNP hybrid scaolds were then utilized to
achieve optical activation of cultured neurons expressing
ChR2. Mouse hippocampal neurons were isolated from post-
natal day 0 (P0) mice pups and plated on the hybrid scaold
surface pre-coated with Matrigel. Thereafter, the neuronal cul-
tures were transduced with ChR2-tdTomato via lentiviruses
after 45daysin vitro (DIV) growth. The neurons attached and
showed complex morphology with extensive dendritic branch-
ing by 14 DIV (Fig. S7 in ESI). Cell viability assay further con-
firmed that the hybrid scaold did not have any adverse
eects on neuronal survival (Fig. S8 in ESI). SEM images
display neurons cultured on the polymer scaold with uni-
formly distributed UCNPs, thus allowing high localization of
UCNPs in close cellular proximity (Fig. 3c).
At 1415 DIV, we conducted whole-cell patch clamping
experiments to measure the light-mediated neuronal response.
The whole-cell patch clamp technique is a method to record
the ionic current flow across the neuronal membrane, as well
as changes in the membrane potential, in response to an
applied stimuli (e.g. light).
32
Since ChR2 is a light-gated cation
channel, the opening of this channel upon light illumination
Fig. 3 Blue-emitting UCNPs were embedded within thin polymer lms of PLGA and cultured with hippocampal neurons. (a) Schematic depicting
preparation of poly(lactic-co-glycolic acid) (PLGA)-embedded UCNP hybrid scaolds for hippocampal neuronal cultures. (b) Photographic image of
the exible hybrid scaold lm. The blue luminescence under 980 nm laser excitation illustrates the encapsulation of UCNPs throughout the PLGA
lm. Scanning electron microscopy (SEM) image shows the distribution of the UCNPs within the PLGA lm. Scale bar: 500 nm (bottom), 100 nm
(inset). (c) Scanning electron microscopy (SEM) image of a hippocampal neuron (pseudo-colored red for contrast) cultured on the polymerUCNP
hybrid scaolds at 14 DIV. Scale bar: 5 µm (left), 200 nm (right).
Communication Nanoscale
Nanoscale This journal is © The Royal Society of Chemistry 2015
Published on 23 September 2015. Downloaded by RUTGERS STATE UNIVERSITY on 29/09/2015 15:59:38.
View Article Online
would facilitate the influx of cations and lead to an inward
current flow to drive neuronal depolarization.
2,17
The mem-
brane-localized expression of ChR2 was first confirmed by the
presence of tdTomato fluorescence using confocal microscopy
(Fig. 4a). Not surprisingly, the inward current response could
be induced in these cells when light-emitting diode (LED)-
generated 470 nm light was supplied via the microscope objec-
tives (Fig. 4b). We then delivered 980 nm NIR light using an
external optical cable setup (Fig. S9 in ESI). Remarkably, an
inward current response was immediately evident upon NIR
light illumination, similar as that observed by using the con-
ventional 470 nm light (Fig. 4b).
While the presence of an inward current flow is an indi-
cator of successful UCNP-mediated optogenetic control, the
generation of nerve impulses (i.e. action potentials) would
provide stronger and more reliable functional evidence for our
approach. Nerve impulses mediate the information flow in the
nervous system, and can only be generated by a sucient
increase (i.e. depolarization) in the membrane potential past a
predefined threshold.
33
Given that the time course of up-
conversion in UCNPs is less than half a millisecond (Fig. S10
in ESI), we were able to apply low NIR pulse widths that are
generally used for optogenetic studies. In our studies, we
checked for nerve impulse generation by applying brief pulses
(3 ms pulse duration) of light to neurons under current-clamp
recording mode. Remarkably, nerve impulses elicited with
980 nm NIR illumination were comparable to those elicited
with 470 nm light (Fig. 4c), indicating a sucient blue lumine-
scence from the UCNPs to activate ChR2 and drive neuronal
depolarization beyond the nerve impulse firing threshold.
Moreover, 980 nm illumination of the ChR2-expressing
neurons cultured on the hybrid scaolds enabled the gene-
ration of time-locked, sustained naturalistic trains of impulses
with millisecond-timescale temporal resolution, in response to
light pulses delivered at 1 Hz, 5 Hz and 10 Hz (Fig. 4d).
Impulses were generated with frequencies up to 20 Hz using
NIR light (Fig. S11 in ESI). This is in contrast to 980 nm illu-
mination of control substrates, i.e. ChR2-infected neurons on
PLGA substrates (Fig. S12 in ESI) and non-infected neurons
on PLGAUCNP substrates (Fig. S13 in ESI), which showed
negligible membrane depolarization and a lack of nerve
impulse generation. This indicates the inability of 980 nm NIR
light alone to activate ChR2-expressing neurons. The mem-
brane depolarization and the reliable generation of action
Fig. 4 Channelrhodopsin-expressing neurons grown on polymerUCNP lms exhibit robust excitatory activation upon NIR-light illumination, com-
parable to blue LED illumination. (a) Hippocampal neurons expressing ChR2-tdTomato (red). Scale bar: 50 µm. (b) Representative traces of inward
current ow in voltage-clamped neuron evoked by 470 nm light (5 mW) and 980 nm light (1 W). (c) Magnied action potential induced by 470 nm
light (top) and 980 nm light (bottom). (d) Representative traces showing repetitive action potentials in a current-clamped hippocampal neuron
evoked by 1 Hz, 5 Hz and 10 Hz train of light pulses from 470 nm light (top; 250 mW, 3 ms pulse width) and 980 nm light (bottom; 1 W, 3 ms pulse
width).
Nanoscale Communication
This journal is © The Royal Society of Chemistry 2015 Nanoscale
Published on 23 September 2015. Downloaded by RUTGERS STATE UNIVERSITY on 29/09/2015 15:59:38.
View Article Online
potentials described above was obtained for polymer films
containing a minimal UCNP concentration of 8.3 µg mm
2
,
wherein lower concentrations did not generate action
potentials.
The physicochemical properties of the upconversion nano-
material can play a significant role in determining the overall
eectiveness of our approach. For instance, we had initially
considered employing upconversion nanomaterials in the
form of nanorods, due to closer resemblance to bulk
materials.
18
These upconversion nanorods (UCNRs) were syn-
thesized as reported previously,
18
using the Yb
3+
/Tm
3+
dopants
to achieve a blue luminescence spectra similar to the core
shell UCNPs shown in Fig. 2 (Fig. S14 in ESI). These rod-
shaped particles, with a length of about 200 nm and width of
50 nm, were embedded within PLGA films and cultured with
neurons (Fig. S15 in ESI). However, the whole-cell patch
clamping experiments showed inconsistent and unreliable
nerve impulse generation, especially at higher frequency
pulses (Fig. S16 in ESI). In addition, nerve impulse generation
with the UCNR-based hybrid scaolds required higher NIR
power (2 W) and longer NIR pulse durations (50 ms) compared
to the coreshell UCNP-based hybrid scaolds (1 W, 3 ms). In
fact, coreshell UCNP-based hybrid scaolds enabled success-
ful generation of action potentials at longer NIR pulse duration
as well, in the form of sustained spikelets (Fig. S17 in ESI).
The ineectiveness of UCNRs can be attributed to multiple
factors, including non-uniformity and random orientation
after film formation (Fig. S18 in ESI), as well as surface-
quenching eects from the lack of an inert shell (complete
shell formation on UCNRs is a technical challenge due to
highly anisotropic particle growth
34
). Besides, the larger size
and rod-like morphology of UCNRs makes them less favorable
when considering future applications for in vivo studies.
35
In
this way, the design and systematic testing of nanomaterials is
invaluable for evaluating their prospects in neural applications
such as optogenetics.
In summary, we have developed a novel and promising
proof-of-concept/method as a complementary technique to
expand the optogenetic toolbox. Our approach is unique in
that we employ UCNPs as mediators to convert NIR light into
opsin-activating visible light. From an application perspective,
UCNPs can be excited with relatively inexpensive continuous
wave (CW) diode lasers; this is in stark contrast to two-photon
approaches, which require high-energy femtosecond pulsed
lasers and instrumentation for raster scanning of a focused
beam over the region of interest.
36
Moreover, while conventional
approaches focus on engineering new opsin-variants to impart
red-shifted spectral sensitivity,
37,38
our approach entailed syn-
thetically-tuning UCNPs to emit at a specific wavelength of
light (e.g. 475 nm blue light) upon NIR excitation to activate
ChR2. In this way, our current in vitro approach can be useful
to assess the UCNP-mediated stimulation of a variety of
dierent opsins, which exhibit peak sensitivity to dierent
wavelengths of light (e.g. green, yellow) and can be excitatory
or inhibitory.
9
In other words, a library of combinatorial
UCNPs can be systematically designed and easily tested for sti-
mulating a corresponding library of well-established opsins.
This oers an additional wavelength for optogenetic control,
which can facilitate multiplexed stimulation and spatio-
temporally confine emission to regions containing UCNPs.
Such a level of control can help explore specific biological
questions at the single-cell level on these unique neural-
material interfaces, which are not only biocompatible but also
provide a biologically-relevant functionality. With rising inter-
est in improving control over neuronal activity and function,
creating eective interfaces between neurons and external
materials will be invaluable. Overall, the integration of chemi-
cal control and nanotechnology with optogenetics holds great
potential for advancing applications in neuroscience research.
Acknowledgements
K.-B. Lee acknowledges financial support from the National
Institute of Health (NIH) Directors New Innovator Award
[1DP20D006462-01], National Institute of Neurological Dis-
orders and Stroke (NINDS) of the NIH [1R21NS085569-02],
N. J. Commission on Spinal Cord grant [CSR13ERG005],
National Science Foundation (NSF) [NSF CHE-1429062] and
the Rutgers IAMDN. Z. P. Pang acknowledges financial support
from National Institute on Drug Abuse (NIDA) R21 DA035594,
Sinsheimer Scholar Award and Robert Wood Johnson Foun-
dation. We would like to thank Benjamin Deibert for help with
PXRD, Dr. Tae-Hyung Kim for help with AFM and Hudifah
Rabie for help with UCNP synthesis.
References
1 A. P. Alivisatos, A. M. Andrews, E. S. Boyden, M. Chun,
G. M. Church, K. Deisseroth, J. P. Donoghue, S. E. Fraser,
J. Lippincott-Schwartz, L. L. Looger, S. Masmanidis,
P. L. McEuen, A. V. Nurmikko, H. Park, D. S. Peterka,
C. Reid, M. L. Roukes, A. Scherer, M. Schnitzer,
T. J. Sejnowski, K. L. Shepard, D. Tsao, G. Turrigiano,
P. S. Weiss, C. Xu, R. Yuste and X. Zhuang, ACS Nano, 2013,
7, 18501866.
2 E. S. Boyden, F. Zhang, E. Bamberg, G. Nagel and
K. Deisseroth, Nat. Neurosci., 2005, 8, 12631268.
3 F. Zhang, V. Gradinaru, A. R. Adamantidis, R. Durand,
R. D. Airan, L. de Lecea and K. Deisseroth, Nat. Protoc.,
2010, 5, 439456.
4 K. M. Tye and K. Deisseroth, Nat. Rev. Neurosci., 2012, 13,
251266.
5 C. Brieke, F. Rohrbach, A. Gottschalk, G. Mayer and
A. Heckel, Angew. Chem., Int. Ed., 2012, 51, 84468476.
6 A. S. Chuong, M. L. Miri, V. Busskamp, G. A. Matthews,
L. C. Acker, A. T. Sorensen, A. Young, N. C. Klapoetke,
M. A. Henninger, S. B. Kodandaramaiah, M. Ogawa,
S. B. Ramanlal, R. C. Bandler, B. D. Allen, C. R. Forest,
B. Y. Chow, X. Han, Y. Lin, K. M. Tye, B. Roska, J. A. Cardin
and E. S. Boyden, Nat. Neurosci., 2014, 17, 11231129.
Communication Nanoscale
Nanoscale This journal is © The Royal Society of Chemistry 2015
Published on 23 September 2015. Downloaded by RUTGERS STATE UNIVERSITY on 29/09/2015 15:59:38.
View Article Online
7 J. Y. Lin, P. M. Knutsen, A. Muller, D. Kleinfeld and
R. Y. Tsien, Nat. Neurosci., 2013, 16, 14991508.
8 N. C. Klapoetke, Y. Murata, S. S. Kim, S. R. Pulver,
A. Birdsey-Benson, Y. K. Cho, T. K. Morimoto,
A. S. Chuong, E. J. Carpenter, Z. Tian, J. Wang, Y. Xie,
Z. Yan, Y. Zhang, B. Y. Chow, B. Surek, M. Melkonian,
V. Jayaraman, M. Constantine-Paton, G. K. Wong and
E. S. Boyden, Nat. Methods, 2014, 11, 338346.
9 O. Yizhar, L. E. Fenno, T. J. Davidson, M. Mogri and
K. Deisseroth, Neuron, 2011, 71,934.
10 F. Wang and X. G. Liu, Chem. Soc. Rev., 2009, 38, 976989.
11 Z. Gu, L. Yan, G. Tian, S. Li, Z. Chai and Y. Zhao, Adv.
Mater., 2013, 25, 37583779.
12 G. Chen, H. Qiu, P. N. Prasad and X. Chen, Chem. Rev.,
2014, 114, 51615214.
13 Y.-H. Chien, Y.-L. Chou, S.-W. Wang, S.-T. Hung,
M.-C. Liau, Y.-J. Chao, C.-H. Su and C.-S. Yeh, ACS Nano,
2013, 7, 85168528.
14 D. Ni, J. Zhang, W. Bu, H. Xing, F. Han, Q. Xiao, Z. Yao,
F. Chen, Q. He, J. Liu, S. Zhang, W. Fan, L. Zhou, W. Peng
and J. Shi, ACS Nano, 2014, 8, 12311242.
15 F. Wang, D. Banerjee, Y. Liu, X. Chen and X. Liu, Analyst,
2010, 135, 18391854.
16 F. Zhang, J. Vierock, O. Yizhar, L. E. Fenno, S. Tsunoda,
A. Kianianmomeni, M. Prigge, A. Berndt, J. Cushman,
J. Polle, J. Magnuson, P. Hegemann and K. Deisseroth, Cell,
2011, 147, 14461457.
17 G. Nagel, T. Szellas, W. Huhn, S. Kateriya, N. Adeishvili,
P. Berthold, D. Ollig, P. Hegemann and E. Bamberg, Proc.
Natl. Acad. Sci. U. S. A., 2003, 100, 1394013945.
18 F. Wang, Y. Han, C. S. Lim, Y. H. Lu, J. Wang, J. Xu,
H. Y. Chen, C. Zhang, M. H. Hong and X. G. Liu, Nature,
2010, 463, 10611065.
19 F. Wang and X. G. Liu, J. Am. Chem. Soc., 2008, 130, 5642
5643.
20 G. S. Yi and G. M. Chow, Adv. Funct. Mater., 2006, 16, 2324
2329.
21 J. Y. Lin, M. Z. Lin, P. Steinbach and R. Y. Tsien, Biophys. J.,
2009, 96, 18031814.
22 Z. Li and Y. Zhang, Nanotechnology, 2008, 19, 345606.
23 N. Bogdan, F. Vetrone, G. A. Ozin and J. A. Capobianco,
Nano Lett., 2011, 11, 835840.
24 F. Wang, J. Wang and X. Liu, Angew. Chem., Int. Ed., 2010,
49, 74567460.
25 F. Zhang, R. Che, X. Li, C. Yao, J. Yang, D. Shen,
P. Hu, W. Li and D. Zhao, Nano Lett., 2012, 12, 2852
2858.
26 R. Deng, F. Qin, R. Chen, W. Huang, M. Hong and X. Liu,
Nat. Nanotechnol., 2015, 10, 237242.
27 H. Liu, C. T. Xu, D. Lindgren, H. Xie, D. Thomas,
C. Gundlach and S. Andersson-Engels, Nanoscale, 2013, 5,
47704775.
28 C. T. Xu, P. Svenmarker, H. Liu, X. Wu, M. E. Messing,
L. R. Wallenberg and S. Andersson-Engels, ACS Nano, 2012,
6, 47884795.
29 G. Orive, E. Anitua, J. L. Pedraz and D. F. Emerich, Nat. Rev.
Neurosci., 2009, 10, 682692.
30 F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. Le Breton
and V. Préat, J. Controlled Release, 2012, 161, 505522.
31 E. Bible, D. Y. S. Chau, M. R. Alexander, J. Price,
K. M. Shakesheand M. Modo, Biomaterials, 2009, 30,
29852994.
32 M. Karmazinova and L. Lacinova, Physiol. Res., 2010, 59,
S1S7.
33 B. P. Bean, Nat. Rev. Neurosci., 2007, 8, 451465.
34 C. Zhang and J. Y. Lee, ACS Nano, 2013, 7, 43934402.
35 Y. Geng, P. Dalhaimer, S. Cai, R. Tsai, M. Tewari,
T. Minko and D. E. Discher, Nat. Nanotechnol., 2007, 2,
249255.
36 Y. I. Park, K. T. Lee, Y. D. Suh and T. Hyeon, Chem. Soc.
Rev., 2015, 44, 13021317.
37 A. M. Packer, D. S. Peterka, J. J. Hirtz, R. Prakash,
K. Deisseroth and R. Yuste, Nat. Methods, 2012, 9, 1202
1205.
38 R. Prakash, O. Yizhar, B. Grewe, C. Ramakrishnan,
N. Wang, I. Goshen, A. M. Packer, D. S. Peterka, R. Yuste,
M. J. Schnitzer and K. Deisseroth, Nat. Methods, 2012, 9,
11711179.
Nanoscale Communication
This journal is © The Royal Society of Chemistry 2015 Nanoscale
Published on 23 September 2015. Downloaded by RUTGERS STATE UNIVERSITY on 29/09/2015 15:59:38.
View Article Online
Article
Full-text available
Degeneration of photoreceptors in the retina is a leading cause of blindness, but commonly leaves the retinal ganglion cells (RGCs) and/or bipolar cells extant. Consequently, these cells are an attractive target for the invasive electrical implants colloquially known as “bionic eyes.” However, after more than two decades of concerted effort, interfaces based on conventional electrical stimulation approaches have delivered limited efficacy, primarily due to the current spread in retinal tissue, which precludes high-acuity vision. The ideal prosthetic solution would be less invasive, provide single-cell resolution and an ability to differentiate between different cell types. Nanoparticle-mediated approaches can address some of these requirements, with particular attention being directed at light-sensitive nanoparticles that can be accessed via the intrinsic optics of the eye. Here we survey the available known nanoparticle-based optical transduction mechanisms that can be exploited for neuromodulation. We review the rapid progress in the field, together with outstanding challenges that must be addressed to translate these techniques to clinical practice. In particular, successful translation will likely require efficient delivery of nanoparticles to stable and precisely defined locations in the retinal tissues. Therefore, we also emphasize the current literature relating to the pharmacokinetics of nanoparticles in the eye. While considerable challenges remain to be overcome, progress to date shows great potential for nanoparticle-based interfaces to revolutionize the field of visual prostheses.
Article
Full-text available
Many essential biological processes are triggered by the proximity of molecules. Meanwhile, diverse approaches in synthetic biology, such as new biological parts or engineered cells, have opened up avenues to precisely control the proximity of molecules and eventually downstream signaling processes. This also applies to a main Ca2+ entry pathway into the cell, the so-called Ca2+ release-activated Ca2+ (CRAC) channel. CRAC channels are among other channels are essential in the immune response and are activated by receptor–ligand binding at the cell membrane. The latter initiates a signaling cascade within the cell, which finally triggers the coupling of the two key molecular components of the CRAC channel, namely the stromal interaction molecule, STIM, in the ER membrane and the plasma membrane Ca2+ ion channel, Orai. Ca2+ entry, established via STIM/Orai coupling, is essential for various immune cell functions, including cytokine release, proliferation, and cytotoxicity. In this review, we summarize the tools of synthetic biology that have been used so far to achieve precise control over the CRAC channel pathway and thus over downstream signaling events related to the immune response.
Article
Optogenetics, a technique that employs light for neuromodulation, has revolutionized the study of neural mechanisms and the treatment of neurological disorders due to its high spatiotemporal resolution and cell-type specificity. However, visible light, particularly blue and green light, commonly used in conventional optogenetics, has limited penetration in biological tissue. This limitation necessitates the implantation of optical fibers for light delivery, especially in deep brain regions, leading to tissue damage and experimental constraints. To overcome these challenges, the use of orange-red and infrared light with greater tissue penetration has emerged as a promising approach for tetherless optical neuromodulation. In this review, we provide an overview of the development and applications of tetherless optical neuromodulation methods with long wavelengths. We first discuss the exploration of orange-red wavelength-responsive rhodopsins and their performance in tetherless optical neuromodulation. Then, we summarize two novel tetherless neuromodulation methods using near-infrared light: upconversion nanoparticle-mediated optogenetics and photothermal neuromodulation. In addition, we discuss recent advances in mid-infrared optical neuromodulation.
Article
Full-text available
Near‐infrared (NIR) light is well‐suited for the optical imaging and wireless phototherapy of malignant diseases because of its deep tissue penetration, low autofluorescence, weak tissue scattering, and non‐invasiveness. Rare earth nanoparticles (RENPs) are promising NIR‐responsive materials, owing to their excellent physical and chemical properties. The 4f electron subshell of lanthanides, the main group of rare earth elements, has rich energy‐level structures. This facilitates broad‐spectrum light‐to‐light conversion and the conversion of light to other forms of energy, such as thermal and chemical energies. In addition, the abundant loadable and modifiable sites on the surface offer favorable conditions for the functional expansion of RENPs. In this review, the authors systematically discuss the main processes and mechanisms underlying the response of RENPs to NIR light and summarize recent advances in their applications in optical imaging, photothermal therapy, photodynamic therapy, photoimmunotherapy, optogenetics, and light‐responsive drug release. Finally, the challenges and opportunities for the application of RENPs in optical imaging and wireless phototherapy under NIR activation are considered.
Article
The field of neuromodulation has experienced significant advancements in the past decade, owing to breakthroughs in disciplines such as materials science, genetics, bioengineering, photonics, and beyond. The convergence of these fields has resulted in the development of nanotransducers, devices that harness the synergies of these diverse disciplines. These nanotransducers, essential for neuromodulation, often draw inspiration from energy conversion processes found in nature for their unique modalities. In this review, we will delve into the latest advancements in wireless neuromodulation facilitated by optical, magnetic, and mechanical nanotransducers. We will examine their working principles, properties, advantages, and limitations in comparison to current methods for deep brain neuromodulation, highlighting the impact of natural systems on their design and functionality. Additionally, we will underscore potential future directions, emphasizing how continued progress in materials science, neuroscience, and bioengineering might expand the horizons of what is achievable with nanotransducer-enabled neuromodulation.
Article
Ion channel are responsible for the propagation and integration of electrical signals in physiological processes. Over‐activation or dysfunction of ion channel plays an important role in physiological and pathological processes and is an important research object for disease treatment. With the widespread application of optical technologies of near infrared (NIR) light responsive materials, the precise regulation of biological processes through optical control, featuring non‐invasive, remote control, and high flexibility, has penetrated the physiological processes. In recent years, an increasing number of light‐stimulated materials have been developed and utilized, with stable properties, easy modification, and sensitive response, enabling precise control of biological processes at the forefront of biomedical research. This review summarizes NIR responsive materials in ion channel regulation and elucidates their action mechanism in regulating ion channel‐related diseases. It is hoped that this review can provide foundation of research for future light‐stimulated materials, promote the application of light‐stimulated materials in biomedical engineering, and be useful for clinical disease treatment. This article is protected by copyright. All rights reserved
Article
Biomineralization refers to the process through which minerals nucleate in a structured manner to form specific crystal structures by the regulating of biomacromolecules. Biomineralization occurs in bones and teeth within the human body, where collagen acts as a template for the nucleation of hydroxyapatite (HA) crystals. Similar to collagen, silk proteins spun by silkworms can also serve as templates for the nucleation and growth of inorganic substances at interfaces. By enabling the binding of silk proteins to inorganic minerals, the process of biomineralization enhances the properties of silk-based materials and broadens their potential applications, rendering them highly promising for use in biomedical applications. In recent years, the development of biomineralized materials using silk proteins has garnered considerable attention in the biomedical field. This comprehensive review outlines the mechanism of biomineral formation mediated by silk proteins, as well as various biomineralization methods used to prepare silk-based biomineralized materials (SBBMs). Additionally, we discuss the physicochemical properties and biological functions of SBBMs, and their potential applications in various fields such as bioimaging, cancer therapy, antibacterial treatments, tissue engineering, and drug delivery. In conclusion, this review highlights the significant role that SBBMs can play in the biomedical field.
Article
Present day strategies for delivery of wireless photodynamic therapy (PDT) to deep-seated targets are limited by the inadequacy of irradiance and insufficient therapeutic depth. Here we report the design and preclinical validation of a flexible wireless upconversion nanoparticle (UCNP) implant (SIRIUS) that is capable of large field, high intensity illumination for PDT of deep-seated tumors. The implant achieves this by incorporating submicrometer core-shell-shell NaYF4 UCNPs into its design, which significantly enhances upconversion efficiency and mitigates light loss from surface quenching. We demonstrate the efficacy of SIRIUS UCNP implant mediated PDT in preclinical breast cancer disease models. In our in vitro experiments, SIRIUS directed 5-Aminolevulinic Acid (5-ALA) based wireless PDT leads to significant reactive oxygen species (ROS) generation and tumor apoptosis in hormonal receptor+/HER2+ (MCF7) and triple-negative (MDA-MB-231) breast cancer cell lines. In our in vivo rodent model, SIRIUS-driven PDT is shown to be significant in regressing tumors when applied to orthotopically inoculated breast tumors. Following successful preclinical validation, we also describe a clinical prototype of UCNP breast implant with potential dual cosmetic and onco-therapeutic functions. SIRIUS is an upconversion breast implant for wireless PDT that fulfils all the design prerequisites necessary for seamless clinical translation.
Article
Full-text available
Developing light-harvesting materials with tunable emission colours has always been at the forefront of colour display technologies. The variation in materials composition, phase and structure can provide a useful tool for producing a wide range of emission colours, but controlling the colour gamut in a material with a fixed composition remains a daunting challenge. Here, we demonstrate a convenient, versatile approach to dynamically fine-tuning emission in the full colour range from a new class of core-shell upconversion nanocrystals by adjusting the pulse width of infrared laser beams. Our mechanistic investigations suggest that the unprecedented colour tunability from these nanocrystals is governed by a non-steady-state upconversion process. These findings provide keen insights into controlling energy transfer in out-of-equilibrium optical processes, while offering the possibility for the construction of true three-dimensional, full-colour display systems with high spatial resolution and locally addressable colour gamut.
Article
Full-text available
Optogenetic inhibition of the electrical activity of neurons enables the causal assessment of their contributions to brain functions. Red light penetrates deeper into tissue than other visible wavelengths. We present a red-shifted cruxhalorhodopsin, Jaws, derived from Haloarcula (Halobacterium) salinarum (strain Shark) and engineered to result in red light-induced photocurrents three times those of earlier silencers. Jaws exhibits robust inhibition of sensory-evoked neural activity in the cortex and results in strong light responses when used in retinas of retinitis pigmentosa model mice. We also demonstrate that Jaws can noninvasively mediate transcranial optical inhibition of neurons deep in the brains of awake mice. The noninvasive optogenetic inhibition opened up by Jaws enables a variety of important neuroscience experiments and offers a powerful general-use chloride pump for basic and applied neuroscience.
Article
Full-text available
Optogenetic tools enable examination of how specific cell types contribute to brain circuit functions. A long-standing question is whether it is possible to independently activate two distinct neural populations in mammalian brain tissue. Such a capability would enable the study of how different synapses or pathways interact to encode information in the brain. Here we describe two channelrhodopsins, Chronos and Chrimson, discovered through sequencing and physiological characterization of opsins from over 100 species of alga. Chrimson's excitation spectrum is red shifted by 45 nm relative to previous channelrhodopsins and can enable experiments in which red light is preferred. We show minimal visual system-mediated behavioral interference when using Chrimson in neurobehavioral studies in Drosophila melanogaster. Chronos has faster kinetics than previous channelrhodopsins yet is effectively more light sensitive. Together these two reagents enable two-color activation of neural spiking and downstream synaptic transmission in independent neural populations without detectable cross-talk in mouse brain slice.
Article
Lanthanide-doped upconverting nanoparticles (UCNPs) have recently attracted enormous attention in the field of biological imaging owing to their unique optical properties: (1) efficient upconversion photoluminescence, which is intense enough to be detected at the single-particle level with a (nonscanning) wide-field microscope setup equipped with a continuous wave (CW) near-infrared (NIR) laser (980 nm), and (2) resistance to photoblinking and photobleaching. Moreover, the use of NIR excitation minimizes adverse photoinduced effects such as cellular photodamage and the autofluorescence background. Finally, the cytotoxicity of UCNPs is much lower than that of other nanoparticle systems. All these advantages can be exploited simultaneously without any conflicts, which enables the establishment of a novel UCNP-based platform for wide-field two-photon microscopy. UCNPs are also useful for multimodal in vivo imaging because simple variations in the composition of the lattice atoms and dopant ions integrated into the particles can be easily implemented, yielding various distinct biomedical activities relevant to magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). These multiple functions embedded in a single type of UCNPs play a crucial role in precise disease diagnosis. The application of UCNPs is extended to therapeutic fields such as photodynamic and photothermal cancer therapies through advanced surface conjugation schemes.
Article
Theranostics is a concept of integrating imaging and therapy into a single platform for use in the next generation of personalized medicine to meet the challenges in modern health care. The diagnostic role of theranostic agents reports the presence of a disease, its status, and its response to a specific treatment, while the therapeutic role of the agent can be implemented in several forms. Two-photon-excitation or second harmonic generation contrast agents, which utilize longer wavelength light, have been recently developed to overcome these limitations for imaging of cells and small animals. However, they require expensive ultrashort pulsed lasers to perform the excitation as they involve inefficient nonlinear optical processes. For bioimaging, some of the advantages are virtually zero autofluorescence background to improve signal-to-noise ratio, large anti-Stokes shifts allowing us to easily separate the PL from the excitation wavelength, narrow emission bandwidths allowing ease of multiplexed imaging.
Article
Surgical resection, one of the main clinical treatments of intracranial glioblastoma, bears the potential risk of incomplete excision due to the inherent infiltrative character of the glioblastoma. To maximize the accuracy of surgical resection, the magnetic resonance (MR) and fluorescence imaging are widely used for the tumor preoperative diagnosis and intraoperative positioning. However, present commercial MR contrast agents and fluorescent dyes can only function for single mode of imaging and subject to poor blood-brain barrier (BBB) permeability and non-targeting-specificity, resulting in the apparent risks of inefficient diagnosis and resection of glioblastoma. Considering the unique MR/upconversion luminescence (UCL) bimodal imaging feature of upconversion nanoparticles (UCNPs), herein, we have developed a dual-targeting nanoprobe (ANG/PEG-UCNPs) to cross the BBB, target the glioblastoma, and then function as simultaneous a MR/NIR-to-NIR UCL bimodal imaging agent, which showed a much enhanced imaging performance in comparison with the clinically used single MRI contrast (Gd-DTPA) and fluorescent dye (5-ALA). Moreover, their biocompatibility, especially to brains, was systematically assessed by the histological/hematological examination, indicating a negligible in vivo toxicity. As a proof-of-concept, the ANG/PEG-UCNPs hold the great potential in MR diagnosis and fluorescence positioning of glioblastoma for the efficient tumor surgery.
Article
The major challenge in current chemotherapy is to increase local effective therapeutic concentration of drugs as well as to minimize toxicity and side effects for patients. The targeted delivery of drugs to their desired site of action in a controlled manner plays an essential role in the development of drug formulations. A photocage refers to a caged molecule rendering biologically inert by a photolabile protecting group. Molecules are illuminated with light to liberate caged group, and then become active forms. In this study, we formulate upconversion nanoparticles (UCNPs) as the NIR-triggered targeting and drug delivery vehicles that successfully deliver in vitro and in vivo for near-infrared light photocontrolled targeting, bioimaging, and chemotherapy. It is noted that there has been no report on the systemic administration UCNPs-based drug delivery agents for evaluation of bioimaging and chemotherapy. To achieve phototargeting, the tumor-homing agent, i.e. folic acid, has been constructed as a photoresponsive molecule. For the chemotherapeutic effect, the anti-tumor drug doxorubicin is thiolated on the surface of UCNPs forming disulfide bond that can be cleaved by lysosomal enzymes within the cells. The caged UNCPs can serve as a platform for the improvement of selectively targeting and possible reduction of adverse side effect from chemotherapy.
Article
Channelrhodopsins (ChRs) are used to optogenetically depolarize neurons. We engineered a variant of ChR, denoted red-activatable ChR (ReaChR), that is optimally excited with orange to red light (λ ∼590-630 nm) and offers improved membrane trafficking, higher photocurrents and faster kinetics compared to existing red-shifted ChRs. Red light is less scattered by tissue and is absorbed less by blood than the blue to green wavelengths that are required by other ChR variants. We used ReaChR expressed in the vibrissa motor cortex to drive spiking and vibrissa motion in awake mice when excited with red light through intact skull. Precise vibrissa movements were evoked by expressing ReaChR in the facial motor nucleus in the brainstem and illumination with red light through the external auditory canal. Thus, ReaChR enables transcranial optical activation of neurons in deep brain structures without the need to surgically thin the skull, form a transcranial window or implant optical fibers.
Article
Lanthanide (Ln) doped upconversion nanoparticles (UCNPs) have attracted enormous attention in the recent years due to their unique upconversion luminescent properties that enable the conversion of low-energy photons (near infrared photons) into high-energy photons (visible to ultraviolet photons) via the multiphoton processes. This feature makes them ideal for bioimaging applications with attractive advantages such as no autofluorescence from biotissues and a large penetration depth. In addition, by incorporating advanced features, such as specific targeting, multimodality imaging and therapeutic delivery, the application of UCNPs has been dramatically expanded. In this review, we first summarize the recent developments in the fabrication strategies of UCNPs with the desired size, enhanced and tunable upconversion luminescence, as well as the combined multifunctionality. We then discuss the chemical methods applied for UCNPs surface functionalization to make these UCNPs biocompatible and water-soluble, and further highlight some representative examples of using UCNPs for in vivo bioimaging, NIR-triggered drug/gene delivery applications and photodynamic therapy. In the perspectives, we discuss the need of systematically nanotoxicology data for rational designs of UCNPs materials, their surface chemistry in safer biomedical applications. The UCNPs can actually provide an ideal multifunctionalized platform for solutions to many key issues in the front of medical sciences such as theranostics, individualized therapeutics, multimodality medicine, etc.